S
Zodix
Study
Academic Library
Search
Dashboard
Shelves
Open access
My library
Inbox
Notes
Write
Learn
Alerts
More
Ask your library
Notifications
Quick cite
Review
Search or jump to…
⌘K
Patricia M. Danzon · Study
Home
/
Author
Patricia M. Danzon
33 works
· latest 2018
· 2 institutions
cluster: provisional
ORCID 0000-0002-7236-5194
Follow
Suggest an ORCID correction
h-index
31
i10
33
Citations
5,216
Works here
33
82
83
91
94
97
98
00
02
03
04
05
07
08
12
13
18
Most cited in this library
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]
2018 · 544 citations
Price, Financial Quality, and Capital Flows in Insurance Markets
1997 · 347 citations
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s
2004 · 344 citations
Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
2003 · 317 citations
Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances
2005 · 290 citations
Works
33 shown
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]
Value in Health
·
2018
·
6 authors
·
Open access
544
citations
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]
Value in Health
·
2018
·
13 authors
·
Open access
152
citations
Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]
Value in Health
·
2018
·
6 authors
·
Open access
91
citations
Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context
Health Economics
·
2013
·
3 authors
·
Open access
142
citations
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement
Health Economics
·
2013
·
3 authors
·
Open access
153
citations
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
Advances in health economics and health services research
·
2012
·
2 authors
·
chapter
83
citations
International Prices And Availability Of Pharmaceuticals In 2005
Health Affairs
·
2008
·
2 authors
170
citations
Mergers and acquisitions in the pharmaceutical and biotech industries
Managerial and Decision Economics
·
2007
·
3 authors
236
citations
Biotech‐Pharmaceutical Alliances as a Signal of Asset and Firm Quality
The Journal of Business
·
2005
·
3 authors
173
citations
Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances
Journal of Health Economics
·
2005
·
3 authors
·
Open access
290
citations
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s
Health Economics
·
2004
·
3 authors
344
citations
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
National Bureau of Economic Research
·
2004
·
3 authors
·
report
·
Open access
67
citations
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
Forum for Health Economics & Policy
·
2004
·
2 authors
126
citations
Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
International Journal of Health Care Finance and Economics
·
2003
·
2 authors
·
Open access
317
citations
Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications
Medical Care
·
2003
·
5 authors
85
citations
Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries
Health Affairs
·
2003
·
2 authors
199
citations
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
SSRN Electronic Journal
·
2003
·
3 authors
·
preprint
·
Open access
67
citations
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
National Bureau of Economic Research
·
2002
·
3 authors
·
report
·
Open access
67
citations
The Economics of Gene Therapy and of Pharmacogenetics
Value in Health
·
2002
·
2 authors
·
Open access
90
citations
Does Regulation Drive Out Competition in Pharmaceutical Markets?
The Journal of Law and Economics
·
2000
·
2 authors
·
Open access
237
citations
Cross-national price differences for pharmaceuticals: how large, and why?
Journal of Health Economics
·
2000
·
2 authors
285
citations
The Economics of Parallel Trade
PharmacoEconomics
·
1998
·
1 author
105
citations
International Price Comparisons for Pharmaceuticals
PharmacoEconomics
·
1998
·
2 authors
78
citations
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU
International Journal of the Economics of Business
·
1997
·
1 author
122
citations
Price, Financial Quality, and Capital Flows in Insurance Markets
Journal of Financial Intermediation
·
1997
·
2 authors
·
Open access
347
citations
Price Cutting in Liability Insurance Markets
The Journal of Business
·
1994
·
2 authors
·
Open access
153
citations
A Plan for ‘Responsible National Health Insurance’
Health Affairs
·
1991
·
4 authors
112
citations
Contingent Fees for Personal Injury Litigation
The Bell Journal of Economics
·
1983
·
1 author
122
citations
Disability and Work
Journal of Policy Analysis and Management
·
1983
·
3 authors
·
Open access
55
citations
The Legal Environment of Business
Journal of Policy Analysis and Management
·
1983
·
3 authors
·
other
31
citations
Studies in Public Regulation
Journal of Policy Analysis and Management
·
1982
·
2 authors
·
Open access
110
citations
Knowledge and Decisions
Journal of Policy Analysis and Management
·
1982
·
2 authors
·
Open access
37
citations
The U.S. Steel Industry in Recurrent Crisis: Policy Options in a Competitive World
Journal of Policy Analysis and Management
·
1982
·
2 authors
·
Open access
26
citations